$34.77
0[0.00%]
At close: Apr 18
$34.77
0[0.00%]
PreMarket: 4:00PM EDT
Collegium Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Collegium Pharmaceutical using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | COLL | Q1 | $1.32 | $0.75 | — | — | $144.77M | $147.49M | — | — | Get Alert |
02/22/2024 | PM | COLL | Q4 | $1.09 | $0.66 | $1.58 | 139.39% | $129.62M | $147.82M | $149.75M | 1.30% | Get Alert |
11/07/2023 | PM | COLL | Q3 | $1.10 | $0.52 | $1.34 | 157.69% | $127.01M | $138.53M | $136.71M | -1.31% | Get Alert |
08/03/2023 | PM | COLL | Q2 | $0.33 | $1.22 | $1.26 | 3.28% | $123.55M | $137.98M | $135.55M | -1.76% | Get Alert |
05/04/2023 | PM | COLL | Q1 | $0.42 | $0.31 | $1.32 | 325.81% | $83.75M | $138.47M | $144.77M | 4.55% | Get Alert |
02/23/2023 | PM | COLL | Q4 | -$0.51 | -$0.14 | $1.09 | 878.57% | $27.36M | $125.19M | $129.62M | 3.54% | Get Alert |
11/03/2022 | PM | COLL | Q3 | $0.22 | -$0.13 | $1.10 | 946.15% | $78.84M | $124.45M | $127.01M | 2.06% | Get Alert |
08/04/2022 | PM | COLL | Q2 | $0.27 | $1.45 | $0.33 | -77.24% | $82.94M | $121.80M | $123.55M | 1.44% | Get Alert |
05/10/2022 | PM | COLL | Q1 | $0.41 | $0.90 | $0.42 | -53.33% | $87.72M | $78.88M | $83.75M | 6.18% | Get Alert |
02/24/2022 | PM | COLL | Q4 | $0.20 | $1.04 | -$0.51 | -149.04% | $76.27M | $81.61M | $27.36M | -66.47% | Get Alert |
11/04/2021 | PM | COLL | Q3 | $0.32 | — | $0.22 | — | $79.18M | $84.89M | $78.84M | -7.12% | Get Alert |
08/05/2021 | PM | COLL | Q2 | $0.23 | $0.36 | $0.27 | -25.00% | $78.06M | $84.77M | $82.94M | -2.16% | Get Alert |
05/06/2021 | PM | COLL | Q1 | $0.01 | $0.30 | $0.41 | 36.67% | $76.51M | $81.87M | $87.72M | 7.15% | Get Alert |
02/25/2021 | PM | COLL | Q4 | -$0.07 | $0.29 | $0.20 | -31.03% | $74.20M | $77.41M | $76.27M | -1.47% | Get Alert |
11/05/2020 | PM | COLL | Q3 | -$0.18 | $0.22 | $0.32 | 45.45% | $72.94M | $77.43M | $79.18M | 2.25% | Get Alert |
08/05/2020 | PM | COLL | Q2 | -$0.14 | $0.20 | $0.23 | 15.00% | $75.04M | $74.40M | $78.06M | 4.92% | Get Alert |
05/07/2020 | PM | COLL | Q1 | -$0.29 | $0.37 | $0.01 | -97.30% | $74.52M | $77.08M | $76.51M | -0.74% | Get Alert |
02/27/2020 | PM | COLL | Q4 | -$0.33 | -$0.10 | -$0.07 | 30.00% | $73.43M | $73.33M | $74.20M | 1.19% | Get Alert |
11/06/2019 | PM | COLL | Q3 | -$0.25 | -$0.15 | -$0.18 | -20.00% | $70.18M | $74.46M | $72.94M | -2.04% | Get Alert |
Collegium Pharmaceutical (COLL) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $1.58, which beat the estimate of $0.66.
The Actual Revenue was $149.7M, which beat the estimate of $147.8M.
Browse earnings estimates, EPS, and revenue on all stocks.